Cumulative incidence of recurrence by modified intention-to-treat analysis at Day 42 and study discharge.
- Chanthap Lon (221151)
- Jessica E. Manning (542772)
- Pattaraporn Vanachayangkul (542773)
- Mary So (542774)
- Darapiseth Sea (542775)
- Youry Se (221148)
- Panita Gosi (50858)
- Charlotte Lanteri (542776)
- Suwanna Chaorattanakawee (542777)
- Sabaithip Sriwichai (221166)
- Soklyda Chann (542778)
- Worachet Kuntawunginn (542779)
- Nillawan Buathong (542780)
- Samon Nou (542781)
- Douglas S. Walsh (257138)
- Stuart D. Tyner (224021)
- Jonathan J. Juliano (310365)
- Jessica Lin (51107)
- Michele Spring (201902)
- Delia Bethell (221145)
- Jaranit Kaewkungwal (190918)
- Douglas Tang (542782)
- Char Meng Chuor (542783)
- Prom Satharath (542784)
- David Saunders (221160)
Publication date
March 2014
DOIAbstract
<p>(A) No statistical difference between regimens for all-species recurrence at primary endpoint Day 42 (p = 0.63) and at day of discharge (p = 0.84). (B) In persons with an initial <i>falciparum</i> parasitemia (alone or mixed), there was no difference in true <i>falciparum</i> recrudescence at Day 42 (p = 0.73) and at day of study discharge (p = 0.91). (C) In persons with an initial <i>vivax</i> parasitemia (alone or mixed), there was no difference in <i>vivax</i> recurrence at Day 42 (0.94) and at day of study discharge (p = 0.22).</p
Add to ORKG